• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巢蛋白-1是自然杀伤细胞p44激活受体的一种新型细胞外配体。

Nidogen-1 is a novel extracellular ligand for the NKp44 activating receptor.

作者信息

Gaggero Silvia, Bruschi Maurizio, Petretto Andrea, Parodi Monica, Del Zotto Genny, Lavarello Chiara, Prato Carola, Santucci Laura, Barbuto Alessandra, Bottino Cristina, Candiano Giovanni, Moretta Alessandro, Vitale Massimo, Moretta Lorenzo, Cantoni Claudia

机构信息

Department of Experimental Medicine, University of Genoa, Genoa, Italy.

Dipartimento dei Laboratori di Ricerca, IRCCS Istituto Giannina Gaslini, Genoa, Italy.

出版信息

Oncoimmunology. 2018 Jul 11;7(9):e1470730. doi: 10.1080/2162402X.2018.1470730. eCollection 2018.

DOI:10.1080/2162402X.2018.1470730
PMID:30228939
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6140582/
Abstract

The release of soluble ligands of activating Natural Killer (NK) cell receptors may represent a regulatory mechanism of NK cell function both in physiologic and in pathologic conditions. Here, we identified the extracellular matrix protein Nidogen-1 (NID1) as a ligand of NKp44, an important activating receptor expressed by activated NK cells. When released as soluble molecule, NID1 regulates NK cell function by modulating NKp44-induced IFN-γ production or cytotoxicity. In particular, it also modulates IFN-γ production induced by Platelet-Derived Growth Factor (PDGF)-DD following NKp44 engagement. We also show that NID1 may be present at the cell surface. In this form or when bound to a solid support (bNID1), NID1 fails to induce NK cell cytotoxicity or cytokine release. However, analysis by mass spectrometry revealed that exposure to bNID1 can induce in human NK cells relevant changes in the proteomic profiles suggesting an effect on different biological processes.

摘要

可溶性激活型自然杀伤(NK)细胞受体配体的释放可能代表了一种在生理和病理条件下调节NK细胞功能的机制。在此,我们鉴定出细胞外基质蛋白巢蛋白-1(NID1)是NKp44的配体,NKp44是活化NK细胞表达的一种重要激活受体。当作为可溶性分子释放时,NID1通过调节NKp44诱导的γ干扰素(IFN-γ)产生或细胞毒性来调节NK细胞功能。特别是,它还能调节NKp44激活后血小板衍生生长因子(PDGF)-DD诱导的IFN-γ产生。我们还表明,NID1可能存在于细胞表面。以这种形式或与固相支持物结合(bNID1)时,NID1无法诱导NK细胞的细胞毒性或细胞因子释放。然而,质谱分析显示,暴露于bNID1可诱导人类NK细胞蛋白质组图谱发生相关变化,提示其对不同生物学过程有影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a892/6140582/634ed10d855b/koni-07-09-1470730-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a892/6140582/03137383ba5a/koni-07-09-1470730-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a892/6140582/a2cfa896495b/koni-07-09-1470730-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a892/6140582/d38aeb3a4dd6/koni-07-09-1470730-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a892/6140582/a5a0fb6c1ed6/koni-07-09-1470730-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a892/6140582/8a8f35f9c6ae/koni-07-09-1470730-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a892/6140582/09f2349561d6/koni-07-09-1470730-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a892/6140582/ff0f8e61f688/koni-07-09-1470730-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a892/6140582/9a4c2ac9c089/koni-07-09-1470730-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a892/6140582/fb31ef2f368e/koni-07-09-1470730-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a892/6140582/b23c5cfc6a39/koni-07-09-1470730-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a892/6140582/634ed10d855b/koni-07-09-1470730-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a892/6140582/03137383ba5a/koni-07-09-1470730-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a892/6140582/a2cfa896495b/koni-07-09-1470730-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a892/6140582/d38aeb3a4dd6/koni-07-09-1470730-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a892/6140582/a5a0fb6c1ed6/koni-07-09-1470730-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a892/6140582/8a8f35f9c6ae/koni-07-09-1470730-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a892/6140582/09f2349561d6/koni-07-09-1470730-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a892/6140582/ff0f8e61f688/koni-07-09-1470730-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a892/6140582/9a4c2ac9c089/koni-07-09-1470730-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a892/6140582/fb31ef2f368e/koni-07-09-1470730-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a892/6140582/b23c5cfc6a39/koni-07-09-1470730-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a892/6140582/634ed10d855b/koni-07-09-1470730-g011.jpg

相似文献

1
Nidogen-1 is a novel extracellular ligand for the NKp44 activating receptor.巢蛋白-1是自然杀伤细胞p44激活受体的一种新型细胞外配体。
Oncoimmunology. 2018 Jul 11;7(9):e1470730. doi: 10.1080/2162402X.2018.1470730. eCollection 2018.
2
NKp44-NKp44 Ligand Interactions in the Regulation of Natural Killer Cells and Other Innate Lymphoid Cells in Humans.NKp44-NKp44 配体相互作用在人类自然杀伤细胞和其他固有淋巴细胞调节中的作用。
Front Immunol. 2019 Apr 9;10:719. doi: 10.3389/fimmu.2019.00719. eCollection 2019.
3
Interaction of Mycobacterium tuberculosis cell wall components with the human natural killer cell receptors NKp44 and Toll-like receptor 2.结核分枝杆菌细胞壁成分与人类自然杀伤细胞受体 NKp44 和 Toll 样受体 2 的相互作用。
Scand J Immunol. 2013 Jun;77(6):460-9. doi: 10.1111/sji.12052.
4
Imbalance of NKp44(+)NKp46(-) and NKp44(-)NKp46(+) natural killer cells in the intestinal mucosa of patients with Crohn's disease.克罗恩病患者肠道黏膜中 NKp44(+)NKp46(-)和 NKp44(-)NKp46(+)自然杀伤细胞的失衡。
Gastroenterology. 2010 Sep;139(3):882-92, 892.e1-3. doi: 10.1053/j.gastro.2010.05.040. Epub 2010 Jun 1.
5
Natural Killer Cells Control Tumor Growth by Sensing a Growth Factor.自然杀伤细胞通过感知生长因子来控制肿瘤生长。
Cell. 2018 Jan 25;172(3):534-548.e19. doi: 10.1016/j.cell.2017.11.037. Epub 2017 Dec 21.
6
NKp44 triggers NK cell activation through DAP12 association that is not influenced by a putative cytoplasmic inhibitory sequence.NKp44通过与DAP12结合触发自然杀伤细胞激活,这不受假定的细胞质抑制序列的影响。
J Immunol. 2004 Jan 15;172(2):899-906. doi: 10.4049/jimmunol.172.2.899.
7
NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily.NKp44是一种参与活化的人类自然杀伤细胞裂解肿瘤细胞的触发受体,是免疫球蛋白超家族的一个新成员。
J Exp Med. 1999 Mar 1;189(5):787-96. doi: 10.1084/jem.189.5.787.
8
Human NK cytotoxicity against porcine cells is triggered by NKp44 and NKG2D.自然杀伤细胞(NK)对猪细胞的细胞毒性由NKp44和NKG2D触发。
J Immunol. 2005 Oct 15;175(8):5463-70. doi: 10.4049/jimmunol.175.8.5463.
9
Regulation of natural cytotoxicity receptors by heparan sulfate proteoglycans in -cis: A lesson from NKp44.硫酸乙酰肝素蛋白聚糖对自然细胞毒性受体的顺式调节:来自NKp44的启示。
Eur J Immunol. 2015 Apr;45(4):1180-91. doi: 10.1002/eji.201445177. Epub 2015 Jan 21.
10
Regulatory role of NKp44, NKp46, DNAM-1 and NKG2D receptors in the interaction between NK cells and trophoblast cells. Evidence for divergent functional profiles of decidual versus peripheral NK cells.NKp44、NKp46、DNAM-1和NKG2D受体在自然杀伤细胞与滋养层细胞相互作用中的调节作用。蜕膜NK细胞与外周NK细胞功能谱不同的证据。
Int Immunol. 2008 Nov;20(11):1395-405. doi: 10.1093/intimm/dxn105. Epub 2008 Sep 23.

引用本文的文献

1
Human Cytomegalovirus Immune Evasion of Natural Killer Cells: A Virus for All Seasons?人巨细胞病毒对自然杀伤细胞的免疫逃逸:一种四季皆有的病毒?
Pathogens. 2025 Jun 24;14(7):629. doi: 10.3390/pathogens14070629.
2
A genome-wide shRNA screen uncovers a novel potential ligand for NK cell activating receptors.一项全基因组shRNA筛选发现了一种用于自然杀伤细胞激活受体的新型潜在配体。
Front Immunol. 2025 Jun 18;16:1537876. doi: 10.3389/fimmu.2025.1537876. eCollection 2025.
3
Case Report: Proteomic analysis of cerebrospinal fluid in a retinoblastoma patient.

本文引用的文献

1
Natural Killer Cells Control Tumor Growth by Sensing a Growth Factor.自然杀伤细胞通过感知生长因子来控制肿瘤生长。
Cell. 2018 Jan 25;172(3):534-548.e19. doi: 10.1016/j.cell.2017.11.037. Epub 2017 Dec 21.
2
Identification of Nidogen 1 as a lung metastasis protein through secretome analysis.通过分泌蛋白质组分析鉴定巢蛋白1为肺转移蛋白。
Genes Dev. 2017 Jul 15;31(14):1439-1455. doi: 10.1101/gad.301937.117. Epub 2017 Aug 21.
3
The Innate Immune Cross Talk between NK Cells and Eosinophils Is Regulated by the Interaction of Natural Cytotoxicity Receptors with Eosinophil Surface Ligands.
病例报告:视网膜母细胞瘤患者脑脊液的蛋白质组学分析
Front Oncol. 2025 Apr 24;15:1511594. doi: 10.3389/fonc.2025.1511594. eCollection 2025.
4
Recognition of Self and Viral Ligands by NK Cell Receptors.自然杀伤细胞受体对自身和病毒配体的识别。
Immunol Rev. 2025 Jan;329(1):e13435. doi: 10.1111/imr.13435.
5
Germline natural killer cell receptors modulating the T cell response.胚系自然杀伤细胞受体调节 T 细胞反应。
Front Immunol. 2024 Nov 4;15:1477991. doi: 10.3389/fimmu.2024.1477991. eCollection 2024.
6
Claudin2 is involved in the interaction between Megalocytivirus-induced virus-mock basement membrane (VMBM) and lymphatic endothelial cells.Claudin2 参与巨细胞病毒诱导的病毒模拟基底膜(VMBM)与淋巴管内皮细胞的相互作用。
Vet Res. 2024 Nov 6;55(1):143. doi: 10.1186/s13567-024-01404-9.
7
Harnessing the Power of NK Cell Receptor Engineering as a New Prospect in Cancer Immunotherapy.利用自然杀伤细胞受体工程的力量作为癌症免疫治疗的新前景。
Pharmaceutics. 2024 Aug 29;16(9):1143. doi: 10.3390/pharmaceutics16091143.
8
Natural killer cells: a future star for immunotherapy of head and neck squamous cell carcinoma.自然杀伤细胞:头颈部鳞状细胞癌免疫治疗的未来之星。
Front Immunol. 2024 Aug 21;15:1442673. doi: 10.3389/fimmu.2024.1442673. eCollection 2024.
9
Natural Killer cells at the frontline in the fight against cancer.自然杀伤细胞在抗击癌症的第一线。
Cell Death Dis. 2024 Aug 23;15(8):614. doi: 10.1038/s41419-024-06976-0.
10
Human NK cells and cancer.人自然杀伤细胞与癌症。
Oncoimmunology. 2024 Jul 16;13(1):2378520. doi: 10.1080/2162402X.2024.2378520. eCollection 2024.
自然杀伤细胞与嗜酸性粒细胞之间的固有免疫串扰由自然细胞毒性受体与嗜酸性粒细胞表面配体的相互作用所调控。
Front Immunol. 2017 Apr 28;8:510. doi: 10.3389/fimmu.2017.00510. eCollection 2017.
4
Complement factor P is a ligand for the natural killer cell-activating receptor NKp46.补体因子P是自然杀伤细胞激活受体NKp46的一种配体。
Sci Immunol. 2017 Apr 28;2(10). doi: 10.1126/sciimmunol.aam9628.
5
NID1, a new regulator of EMT required for metastasis and chemoresistance of ovarian cancer cells.NID1,一种卵巢癌细胞转移和化疗耐药所需的上皮-间质转化新调节因子。
Oncotarget. 2017 May 16;8(20):33110-33121. doi: 10.18632/oncotarget.16145.
6
Nidogen-1 Degraded by Cathepsin S can be Quantified in Serum and is Associated with Non-Small Cell Lung Cancer.组织蛋白酶S降解的巢蛋白-1可在血清中定量,且与非小细胞肺癌相关。
Neoplasia. 2017 Apr;19(4):271-278. doi: 10.1016/j.neo.2017.01.008. Epub 2017 Mar 7.
7
NKp30 isoforms and NKp30 ligands are predictive biomarkers of response to imatinib mesylate in metastatic GIST patients.NKp30亚型和NKp30配体是转移性胃肠间质瘤患者对甲磺酸伊马替尼反应的预测性生物标志物。
Oncoimmunology. 2016 Apr 25;6(1):e1137418. doi: 10.1080/2162402X.2015.1137418. eCollection 2017.
8
Immunological Mechanisms Underneath the Efficacy of Cancer Therapy.癌症治疗疗效背后的免疫学机制。
Cancer Immunol Res. 2016 Nov;4(11):895-902. doi: 10.1158/2326-6066.CIR-16-0197.
9
Inherent and Tumor-Driven Immune Tolerance in the Prostate Microenvironment Impairs Natural Killer Cell Antitumor Activity.前列腺微环境中的固有和肿瘤驱动免疫耐受会损害自然杀伤细胞的抗肿瘤活性。
Cancer Res. 2016 Apr 15;76(8):2153-65. doi: 10.1158/0008-5472.CAN-15-1965. Epub 2016 Apr 5.
10
Emerging insights into natural killer cells in human peripheral tissues.人体外周组织中自然杀伤细胞的新见解。
Nat Rev Immunol. 2016 Apr 28;16(5):310-20. doi: 10.1038/nri.2016.34.